Gen Z Trusts AI for Health Decisions
The new Better Health Report 2025 from Simon-Kucher and AESGP reveals a digital shift in prevention: AI is becoming a trusted tool in self-care – especially for Gen Z.
BPI launches Radiopharmaceuticals Working Group
BPI has launched the Radiopharmaceuticals Working Group to foster exchange on regulatory, scientific, and healthcare policy challenges in this innovative drug class.
Publicis Health Acquires p-value Group
Publicis Health strengthens its medical communications capabilities across the full product lifecycle by acquiring p-value Group.
Strong Commitment to Cancer Care: Cancer Aid Releases Report
In 2024, German Cancer Aid launched 164 new cancer-fighting projects funded by €181 million in donations – including research, new care models, and patient support.
Pharmacy Day 2026: Save the Date!
On March 25, 2026, the Thuringian Chamber of Pharmacists invites students to the Pharmacy Day in Jena. Under the motto “Your Prescription for Life”, participants will gain exciting insights into the pharmacy profession.
Takeda Relocates German HQ to Berlin
Takeda is relocating the headquarters of Takeda GmbH from Konstanz to Berlin, focusing future operations on Berlin, Oranienburg, and Singen.
Campaign Germany: Submit now for Agency of the Year 2025!
The Campaign Germany Agency of the Year Awards honor the best agencies and standout individuals – submissions open until July 25, 2025!
Nordic Capital and Permira plan takeover of Bavarian Nordic
A consortium led by Nordic Capital and Permira plans to acquire Danish vaccine company Bavarian Nordic in a deal worth around DKK 19 billion.
Pharmacy Crisis Intensifies
The number of pharmacies in Germany has continued to fall sharply in the first half of 2025. The ABDA warns of serious consequences for healthcare delivery.
Engelhard excels with top-rated training program
Engelhard secures 1st place in the 2024 OTC Performance Review in the "Training Program" category – thanks to innovative formats like Selfcare Saturdays and the “Engelhard & Me” app.
Sustainability becomes central to medical care
Sustainability is becoming an increasingly important factor in therapy decisions for physicians in Germany. This is shown by the new Physician Barometer commissioned by AstraZeneca.
Kling Bio partners with Sanofi
Kling Bio partners with Sanofi to discover novel, high-potency antibodies for combating viral diseases using its proprietary Kling-Select B cell platform.
Biotech 2025: Precision Drives Progress
The new Biotech Report 2025 shows: Biopharmaceuticals dominate the market while precision medicine is transforming healthcare. Germany remains a hub for innovation.
medac and Clinigen strengthen APAC cooperation
medac and Clinigen expand their collaboration in the APAC region – six key therapies will be exclusively marketed and distributed.
Elinzanetant Significantly Reduces Hot Flashes in Breast Cancer Patients
Results from the OASIS-4 study show that elinzanetant significantly reduces the frequency and severity of hot flashes in HR+ breast cancer patients – offering a potential new hormone-free treatment option.
Gilead and Global Fund Expand HIV Prevention Access
Gilead will supply lenacapavir at no profit to up to two million people in high-incidence, low-income countries through a partnership with the Global Fund.
Bayer Looks to Supreme Court in Glyphosate Dispute
Bayer welcomes the U.S. Supreme Court’s decision to involve the Solicitor General in the Durnell case – a potential turning point in the glyphosate litigation.
Araris Biotech Wins Strüngmann Award 2025
Araris Biotech has been awarded the Strüngmann Award 2025 for its groundbreaking ADC technology – a milestone for targeted cancer therapies.
Zeller relaxes with a fear-focused twist
Max Zeller Söhne AG draws attention to zeller entspannung with a bold campaign centered around rare phobias. The herbal remedy is repositioned as a solution for stress and anxiety.
Torrent takes over JB Pharma – billion-euro deal in the pharmaceutical sector
Torrent Pharma acquires a majority stake in JB Chemicals & Pharmaceuticals from KKR for over INR 25,000 crore and announces a subsequent merger. The deal significantly strengthens Torrent's market presence in India and globally.